David J. Chaplin
2017
In 2017, David J. Chaplin earned a total compensation of $266.6K as Chief Scientific Officer at OXiGENE, a 34% decrease compared to previous year.
Compensation breakdown
Option Awards | $73,743 |
---|---|
Salary | $192,885 |
Total | $266,628 |
Chaplin received $192.9K in salary, accounting for 72% of the total pay in 2017.
Chaplin also received $73.7K in option awards.
Rankings
In 2017, David J. Chaplin's compensation ranked 13,593rd out of 14,666 executives tracked by ExecPay. In other words, Chaplin earned more than 7.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 13,593 out of 14,666 | 7th |
Division Manufacturing | 5,342 out of 5,772 | 7th |
Major group Chemicals And Allied Products | 1,926 out of 2,075 | 7th |
Industry group Drugs | 1,608 out of 1,731 | 7th |
Industry Pharmaceutical Preparations | 1,233 out of 1,333 | 8th |
Source: SEC filing on May 7, 2018.
Chaplin's colleagues
We found two more compensation records of executives who worked with David J. Chaplin at OXiGENE in 2017.